| Autor: |
Brewster, Marcus E., Druzgala, Pascal J., Anderson, Wesley R., Huang, Ming‐Ju, Bodor, Nicholas, Pop, Emil |
| Zdroj: |
Journal of Pharmaceutical Sciences; January 1995, Vol. 84 Issue: 1 p38-43, 6p |
| Abstrakt: |
Brain‐targeted delivery of estrogens has been achieved by a chemical delivery system (CDS) in which a molecular targetor (1‐methyl‐1,4‐dihydronicotinate) was attached to the 17‐alcohol of estradiol. Optimization of this effect was attempted with the isomeric 3‐phenol ester. Estradiol 3‐nicotinate was prepared with nicotinic anhydride, which selectively acylated the phenol position. Methylation and reduction gave estradiol 3‐(1‐methyl‐1,4‐dihydronicotinate) of the 3‐E2‐CDS. Theoretical and electrochemical investigation indicated that the 3‐E2‐CDS was more stable to oxidation than was the prototype 17‐ester (17‐E2‐CDS). Systemic administration of the 17‐E2‐CDS produced high levels of the corresponding quaternary salt in the brain of rats, which disappeared with an estimated half‐life of > 2 days, but 3‐E2‐CDS dosing resulted in no significant quatemary salt trapping. Pharmacological activity was potent and sustained after 17‐E2‐CDS dosing but transient after 3‐E2‐CDS administration. Thus, the 3‐E2‐CDS reduced the rate of weight gain in male rats but to a lesser extent and for a shorter duration than did the 17‐E2‐CDS. Similar effects were seen on pituitary hypertrophy, reduction in serum androgen concentrations, and involution of prostate and seminal vesicles. The results of these studies suggest that placement of the targeting ester at the phenol position increases dihydropyridine stability but, at the same time, reduces brain sequestration. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Plný text